AdamsD. A.PerryS. (1958). Agranulocytosis associated with thenalidine (Sandosten) tartrate therapy. J. Amer. med. Ass., 167, 1207.
2.
BlantonW. B.OwensM. E. B. (1947). Granulocytopenia due probably to Pyribenzamine. J. Amer. med. Ass., 134, 454.
3.
CahanA. M.MeilmanE.JacobsonB. M. (1949). Agranulocytosis following Pyribenzamine. New Engl. J. Med., 241, 865.
4.
CrumbleyJ. J. (1950). Anemia following use of antihistaminic drugs. J. Amer. med. Ass., 143, 726.
5.
DrakeT. G. (1950). Agranulocytosis during therapy with the antihistaminic agent methaphenilene (Diatrin). J. Amer. med. Ass., 142, 477.
6.
HilkerA. W. (1950). Agranulocytosis from tripelennamine (Pyribenzamine) hydrochloride. J. Amer. med. Ass., 143, 741.
7.
MartlandH. S.GuckJ. K. (1950). Agranulocytosis after antihistaminic therapy. Report of a case following the prolonged use of tripelennamine (Pyribenzamine) hydrochloride. J. Amer. med. Ass., 143, 742.
8.
ParrishA. E.RubensteinN. H.HoweJ. S. (1955). Acute renal insufficiency associated with respiratory infections. Amer. J. Med., 18, 237.
